NCCN VERSION 2 2015

179 / 188

Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®. MS-104
NCCN Guidelines Index
Breast Cancer Table of Contents
Discussion
NCCN Guidelines Version 2.2015
Breast Cancer
Oncol 2010;28:1124-1130. Available at:
.
502. Blackwell KL, Burstein HJ, Storniolo AM, et al. Overall survival
benefit with lapatinib in combination with trastuzumab for patients with
human epidermal growth factor receptor 2-positive metastatic breast
cancer: final results from the EGF104900 Study. J Clin Oncol
2012;30:2585-2592. Available at:
.
503. Hortobagyi GN. Multidisciplinary management of advanced primary
and metastatic breast cancer. Cancer 1994;74:416-423. Available at:
504. Babiera GV, Rao R, Feng L, et al. Effect of primary tumor
extirpation in breast cancer patients who present with stage IV disease
and an intact primary tumor. Ann Surg Oncol 2006;13:776-782.
Available at: .
505. Khan SA, Stewart AK, Morrow M. Does aggressive local therapy
improve survival in metastatic breast cancer? Surgery 2002;132:620-
626. Available at:
506. Rao R, Feng L, Kuerer HM, et al. Timing of surgical intervention for
the intact primary in stage IV breast cancer patients. Ann Surg Oncol
2008;15:1696-1702. Available at:
.
507. Rapiti E, Verkooijen HM, Vlastos G, et al. Complete excision of
primary breast tumor improves survival of patients with metastatic
breast cancer at diagnosis. J Clin Oncol 2006;24:2743-2749. Available
at:
508. Morrow M, Goldstein L. Surgery of the primary tumor in metastatic
breast cancer: closing the barn door after the horse has bolted? J Clin
Oncol 2006;24:2694-2696. Available at:
.
509. Olson JA, Marcom PK. Benefit or bias? The role of surgery to
remove the primary tumor in patients with metastatic breast cancer. Ann
Surg 2008;247:739-740. Available at:
.
510. Badwe R, Parmar V, Hawaldar R, et al. Surgical removal of
primary breast tumor and axillary lymph nodes in women with
metastatic breast cancer at first presentation: a randomized controlled
trial. Presented at: 2013 [abstract]. San Antonio Breast Cancer
Symposium 2013:Abstract S2-02.
511. Soran A, Ozmen V, Ozbas S, et al. Early follow up of a randomized
trial evaluating resection of the primary breast tumor in women
presenting with de novo stage IV breast cancer; Turkish study (protocol
MF07-01) [abstract]. San Antonio Breast Cancer Symposium
2013:Abstract S2-03.
512. Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of
hyperthermia and radiation for superficial tumors. J Clin Oncol
2005;23:3079-3085. Available at:
.
513. Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without
hyperthermia in the treatment of superficial localized breast cancer:
results from five randomized controlled trials. International Collaborative
Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996;35:731-744.
Available at:
514. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response
evaluation criteria in solid tumours: revised RECIST guideline (version
1.1). Eur J Cancer 2009;45:228-247. Available at:
.
515. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results
of cancer treatment. Cancer 1981;47:207-214. Available at: